This Week in Pharmacy

Osad

• 250 Years of Freedom - 4th of July Special | TWIRx 03.07.2026 59min

  Today e celebrate 250 Years of Freedom during this 4th of July special with Scotty Sykes with Sykes & Company Pharmacy Accounting Experts. Next, a special interview with Virginia Halsey SVP of Strategy and Product Management and Brad Engels Product Manager at First Databank (FDB).  Today's TWIRx is sponsored by Sykes & Company  250 Years of Freedom - 4th of July Special | TWIRx 
• PBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine | TWIRx 26.06.2026 1t 19min

  THIS WEEK IN PHARMACYPBM Truth, Cash-Based Pharmacy, and Psychedelics in Medicine Presented by SuiteRx Pharmacy Software TechnologiesLearn more at SuiteRx.com Episode Overview On this episode of This Week in Pharmacy, Todd Eury brings together two timely conversations focused on pharmacy transformation, advocacy, clinical education, and the future role of pharmacists in healthcare. First, Todd welcomes Brad Hart, owner of Forest Park Pharmacy, a cash-based independent pharmacy model challenging the traditional reimbursement structure many pharmacies operate under. Brad has become a powerful advocate for pharmacy transparency, using TikTok and social media to expose current PBM practices, share data, and speak directly to patients, pharmacy owners, and policymakers about the realities facing independent pharmacies. Brad’s message is clear: patients deserve transparency, pharmacy owners deserve fair treatment, and the profession needs more voices willing to educate the public with facts and truth. In the second half of the episode, Todd is joined by Dr. Colby Burns and Dr. Andy Krut from the Psychedelic Pharmacists Association. This discussion helps set the groundwork for understanding psychedelics in medicine, the evolving role of pharmacists in psychedelic education, and the clinical potential of psychotropic therapies historically limited by regulation, stigma, and lack of provider education. As interest in psychedelic-assisted care grows, pharmacists must be part of the conversation. Dr. Burns and Dr. Krut explain why pharmacist education, medication safety, and clinical understanding are essential as healthcare explores emerging approaches to mental health, trauma, pain, and complex patient care. Featured Guests Brad HartOwner, Forest Park Pharmacy Dr. Colby BurnsPsychedelic Pharmacists Association Dr. Andy KrutPsychedelic Pharmacists Association Sponsored By This episode of This Week in Pharmacy is brought to you by SuiteRx Pharmacy Software Technologies. SuiteRx provides pharmacy software solutions designed to support independent pharmacies, improve workflow, enhance patient care, and help pharmacy teams operate more efficiently in today’s demanding healthcare environment. Learn more at SuiteRx.com.
• Modern Pharmacy Media and the Rise of Functional Medicine | TWIRx 12.06.2026 1t 5min

  On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation.   First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today’s rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong.   We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare.   Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John’s University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care.   Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice.   Listen to This Week in Pharmacy on the Pharmacy Podcast Network.Pharmacy’s future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.
• Health Security, Specialty Care & the OTC Products Patients Trust | TWIRx 29.05.2026 1t 11min

  On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most.   We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities.   As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense.   TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession.   Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes.   To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children’s Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm.   For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings.   Sponsored by Perigon Pharmacy 360 Listen & Subscribe Stay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.
• Does Pharmacy Have an Identity Crisis? | TWIRx 22.05.2026 1t 36min

  On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy’s provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.
• U.S. Supreme Court and Generic Drugs | TWIRx 15.05.2026 21min

  This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice. In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment. In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient’s most relevant risk, helping reduce alert fatigue and improve workflow. Finally, we review a federal court ruling in Eli Lilly’s lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue.Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma’s marketing materials and public communications around its generic version of Amarin’s fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies. Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care.
• Expanding Long-Term Care Pharmacy at Home, Delivery Logistics, AI, and Healthcare Misinformation | TWIRx 08.05.2026 54min

  Sponsored by Rx4RouteThis Week in Pharmacy returns with a timely two-part episode focused on pharmacy operations, medication access, and the growing responsibility of healthcare communicators in the age of AI.In our first segment, we welcome Joseph Dymowski, PharmD, CEO of Centennial Pharmacy Services, and Doniyor Sattarov, Vice President of Operations at Rx4Route, for a conversation about expanding long-term care pharmacy at home. As more patients age in place, pharmacies must rethink delivery, logistics, documentation, and patient communication as essential parts of care.Delivery is no longer just a convenience. It is a critical extension of pharmacy services. Reliable routing, real-time tracking, and proof of delivery help pharmacies improve adherence, reduce operational friction, and build stronger trust with patients, caregivers, and providers.Expanding LTC pharmacy-at-home services, building scalable delivery workflows, improving route efficiency, using delivery technology to support compliance, and why logistics may become a major competitive advantage for pharmacies.This episode is sponsored by Rx4Route, pharmacy delivery software designed to help pharmacies streamline delivery operations, optimize routes, track orders, and improve proof-of-delivery workflows.In our second segment, we speak with **Vincent Grippi, CEO of Grippi Media, about the dangers of AI-generated misinformation and the higher standard required in healthcare communications. As AI becomes more common in content creation, communications professionals must protect accuracy, credibility, and patient trust.In healthcare, misinformation can influence clinical understanding, damage reputations, and create confusion across the industry. That is why content for healthcare professionals must be reviewed, verified, and guided by human judgment.AI misinformation in healthcare, responsible content development, source verification, editorial review, subject-matter expertise, and how communicators can use AI without sacrificing trust.This episode connects two critical forms of trust in pharmacy: operational trust at the patient’s door and informational trust across every communication channel.Featured Guests:Joseph Dymowski, PharmD— CEO, Centennial Pharmacy ServicesDoniyor Sattarov— Vice President of Operations, Rx4RouteVincent Grippi— CEO, Grippi Media
• TJM Labs and Pharmacists in Politics | TWIRx 01.05.2026 48min

  Congratulations to Logan Eury and his new wife Emily, got married today, May 1, 2026! This C.O. Bigelow Collab Introduces the 188-Year-Old Pharmacy to a New Generation Abbode is taking over the Carolyn Bessette-Kennedy-approved shop for a month-long pop-up.https://fashionista.com/2026/05/co-bigelow-abbode-pop-up-carolyn-bessette-impact The article highlights how a pop-up and renewed interest in C.O. Bigelow has been fueled by the cultural resurgence of Carolyn Bessette-Kennedy’s minimalist style, amplified by media and social buzz. This renewed attention has driven significant foot traffic and sales, showing how storytelling, nostalgia, and “quiet luxury” aesthetics can translate into real retail impact.   Q&A: Mayo Clinic leaders share strategies for managing high-cost drugs without breaking the bank | Asembia AXS26 Summit https://www.managedhealthcareexecutive.com/view/q-a-mayo-clinic-leaders-share-strategies-for-managing-high-cost-drugs-without-breaking-the-bank-asembia-axs26-summitMayo Clinic leaders emphasize that managing high-cost drugs requires clear definitions, structured formulary review processes, and multidisciplinary collaboration to balance cost, access, and clinical value. They highlight the importance of evaluating safety, efficacy, financial impact, and site-of-care decisions together, while noting that non-340B systems face increasing pressure from rising costs and reimbursement constraints. Ultimately, success depends on stronger alignment between health systems, manufacturers, and payers to sustain access without compromising quality of care. Where Gross-to-net Pressure Actually Lives After LaunchToday’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx.https://www.drugchannels.net/2026/05/where-gross-to-net-pressure-actually.htmlThe article explains that “gross-to-net pressure” isn’t driven by a single factor, but by a combination of rebates, discounts, fees, and policy changes that continue to reshape how drug pricing actually works behind the scenes. As the industry shifts toward a “net pricing” model, traditional rebate-driven strategies are weakening, forcing manufacturers, PBMs, and pharmacies to rethink how value and profits are generated.Today's featured guest is Dr. Ndidiamaka Okpareke PharmD for CongressDr. Ndidiamaka “Didi” Okpareke, PharmD, is a pharmacist, entrepreneur, and political candidate running for Congress in New Mexico’s 1st Congressional District. A first-generation Nigerian-American, she built her career in healthcare after graduating from the University of New Mexico College of Pharmacy and went on to found and lead a successful compounding pharmacy serving her community.  Motivated by nearly two decades of patient care experience, Okpareke entered the political arena to address challenges such as healthcare access, rising costs, and the shortage of providers in New Mexico. Running as a Republican, she emphasizes strengthening healthcare systems, supporting economic growth, and preserving opportunity for future generations, positioning herself as a community-focused leader bringing frontline healthcare insight into public policy.  This special episode highlights how TJM Labs is redefining pharmacy operations through AI-driven automation, bringing together insights from industry leaders Bhavesh Patel, PharmD—CEO of Carepoint Pharmacy—and Jonathan Adly, PharmD, MBA—CEO of TJM Labs. At the center of the conversation is how modern pharmacies are facing rising prescription volumes, staffing constraints, and increasing operational complexity, and why traditional manual workflows can no longer keep pace. TJM Labs addresses this challenge by deploying AI-powered “digital workers” that automate tasks like prescription intake, data entry, and patient communication—allowing pharmacy teams to shift their focus back to patient care and clinical decision-making.  Through the lens of both operator and innovator, the discussion explores how AI is not replacin
• Healing the Sick Care System; Why People Matter | TWIRx 24.04.2026 1t 41min

  Guests:Gil BasheChair Global Health and Purpose at FINN PartnersMaya HajizadaChief Revenue Officer at Rx2GoC. Daniel MullinsProfessor at University of Maryland School of PharmacyMina G Yacoub PharmD BCPSFounder & CEO at Qik Productions
• Clearway Health, John Nosta, Perigon 360, and Psychedelics in Practice | TWIRx 17.04.2026 1t 58min

  TWIRx News:The FDA plans to remove 12 peptide bulk drug substances from Category 2 of the Section 503A compounding list after their nominations were withdrawn. For compounders, the key issue is that this change does not automatically make compounding these substances permissible, leaving pharmacies exposed to ongoing regulatory uncertainty until the FDA makes further decisions.A nationwide Class II recall has been issued for Xanax XR 3 mg tablets in 60-count bottles, lot 8177156, after the product failed dissolution testing. Pharmacists should immediately locate and quarantine affected stock while reminding patients not to stop benzodiazepine therapy suddenly without direction from a healthcare provider.Community pharmacies are taking on a larger role in wound care by serving as an accessible first point of contact for patients with minor injuries. Pharmacists can help assess wounds, recommend appropriate over-the-counter treatment, watch for warning signs of complications, and refer patients for higher-level care when needed.Special sponsor interview with Allison Arant with Clearway Health. Featured interview with  the World's Leading Innovation Theorist John NostaGuests & sponsors of today's TWIRx, Perigon 360 Pharmacy with Chris Antypas PharmD and ed Mills And a bonus interview with Dr. Andy Krut PharmD, on Psychedelics (e.g., LSD, psilocybin, DMT)
• Accountability, Innovation, and Access Across Care | TWIRx 10.04.2026 36min

  This Week in Pharmacy 04-10-2026Sponsored by Outcomes and Independent Pharmacy Cooperative (IPC)On this episode of This Week in Pharmacy, we dig into another high-impact week across the profession with TWIRx news, practice transformation, oncology leadership, pediatric research innovation, and a look ahead to one of specialty pharmacy’s biggest gatherings of the year.This week’s episode is powered by our sponsors, Outcomes and Independent Pharmacy Cooperative (IPC), organizations continuing to support independent pharmacy innovation, patient engagement, and pharmacy performance.In the TWIRx News segment, we cover four important stories shaping the national conversation in pharmacy.First, we discuss the federal fraud case involving a Dearborn Heights pharmacy owner who pleaded guilty in a $1.9 million health care fraud scheme. According to the U.S. Department of Justice, Rabih Hamdan admitted to conspiring to submit false claims for prescription drugs that were either medically unnecessary or never actually dispensed, impacting Medicare, Medicaid, and Blue Cross Blue Shield of Michigan. Federal prosecutors say the fraudulent claims totaled at least $1.9 million over a five-year period.Next, we look at oncology pharmacy leadership through the lens of Amy Seung, who is stepping into the HOPA presidency during a period of rapid acceleration in cancer care. In Pharmacy Times, Seung describes a practice environment where new approvals, indications, toxicity data, and clinical questions are arriving weekly or even daily. She positions HOPA as a key bridge between emerging science and real-world implementation, with this year’s conference emphasizing bispecific therapies, real-world evidence, supportive care, and toxicity management.We also spotlight a powerful research update from the UNC Eshelman School of Pharmacy, where professor David Drewry and student researchers are advancing work on diffuse intrinsic pontine glioma (DIPG), an aggressive pediatric brain cancer with limited treatment options and an average life expectancy of about one year after diagnosis. The team is using an open-science model to accelerate discovery while keeping future therapies more affordable, and they are working with M4K Pharma to advance an ALK2 inhibitor toward a Phase 1 clinical trial.Finally, we feature a practice transformation story from Drug Topics: Gregg Jones, MBA, RPh, made the leap from corporate pharmacy leadership to launching Compass Core Pharmacy, described as Rhode Island’s first cost-plus pharmacy model. The cash-only model focuses on generics, uses AI-driven ordering, serves a growing veterinary segment with more than 1,400 pet prescriptions, and operates as a CLIA-waived pharmacy offering point-of-care testing. It is a compelling example of how pharmacists are reengineering care delivery outside the traditional reimbursement framework.We are also getting ready for Asembia 2026 in Las Vegas, where the Pharmacy Podcast Network will once again provide press coverage with support from Clearway Health. You can find us at booth 1805, where we’ll be capturing conversations that matter across specialty pharmacy, access, patient support, innovation, and care delivery.Our first featured interview is with Nick Baird, Director of Marketing with Outcomes, where we will explore the growing role of pharmacy engagement, patient activation, and value creation in community-based care.Our second interview features Dr. Jen Hammons, PharmD, DrPH, with Health Wagon, a vital community healthcare organization dedicated to serving medically underserved patients through an expanding network of care. In 2024 alone, Health Wagon served 7,291 unique patients through 21,615 patient encounters, supported by five mobile health units, three stationary clinic sites, a dental clinic, a vision clinic, and a pharmacy. Known for hosting one of the nation’s largest health outreach efforts of its kind, Health Wagon continues to expand its impact through the dedi
• DSCSA Compliance and Compounding Leadership | TWIRx 03.04.2026 1t 19min

  TWIRx – April 3, 2026Co-Host: Jesse McCullough On today’s episode of This Week in Pharmacy – TWIRx, we welcome special co-host Jesse McCullough for a timely discussion focused on pharmacy innovation, compliance, advocacy, and the future of the profession. We begin with our featured sponsor segment presented by MatchRx, spotlighting two important voices in pharmacy technology and compliance. Johny Kello, CEO of MatchRx, joins the show alongside Riya Cao, CEO of LSPedia, for an important conversation centered on DSCSA readiness and the evolving world of pharmacy compliance. This discussion explores how pharmacies and supply chain stakeholders can better prepare for regulatory expectations, protect patients, and strengthen operational transparency through smarter compliance solutions. In the second half of the episode, we’re joined by Scott Brunner, CEO of the Alliance for Pharmacy Compounding (APC), for a recap of the Owner Summit 2026 and a look ahead at what’s developing on Capitol Hill. Scott shares insight into the policy landscape impacting pharmacy compounding, the priorities emerging from this year’s summit, and what pharmacy owners and industry leaders should be watching as legislative and regulatory conversations continue to evolve. This episode of TWIRx delivers a strong pulse on the profession—from compliance and interoperability to advocacy and the future of compounding pharmacy. Featured Guests: Johny Kello, CEO, MatchRx Riya Cao, CEO, LSPedia Scott Brunner, CEO, Alliance for Pharmacy Compounding (APC) Episode Topics: DSCSA and pharmacy compliance Supply chain visibility and readiness MatchRx and LSPedia collaboration in pharmacy compliance Owner Summit 2026 recap Capitol Hill updates impacting pharmacy compounding The future of compounding and pharmacy advocacy Sponsored by:MatchRx DSCSA Compliance and Compounding Leadership | TWIRx 
• TJM Labs, Chuck Melendi, and Bruce Kneeland | TWIRx 27.03.2026 1t 11min

  This episode is dedicated to the late Dr. Eric Geyer PharmD. Feautured guest Chuck Melendi Disruptive DialogueSpecial report from Bruce KneelandSponsored by TJM Labs and interview with Jonathan AdlyThis episode is sponsored by YARAL Pharma 
• AI, Pharmacy System Evolution & Emerging Therapies | TWIRx 13.03.2026 1t 23min

  On this week’s This Week in Pharmacy (TWIRx), we explore how innovation, technology, and emerging therapies are reshaping pharmacy practice. From the growing influence of AI in medical information research, to the next generation of pharmacy management systems, and the expanding role of cell and gene therapies, this episode brings together industry leaders to discuss what’s next for pharmacy. Special thanks to this week’s sponsors Cardinal Health, Independent Pharmacy Cooperative (IPC), and Nested Knowledge for supporting the podcast. Segment 1 – AI & the Future of Medical Information with Nested Knowledge Nested Knowledge returns to TWIRx as we welcome back Keith Kallmes, Co-Founder of Nested Knowledge, for an update on how artificial intelligence is transforming the way healthcare professionals access and interpret medical information. Keith explains how AI-powered tools are improving evidence synthesis, systematic literature reviews, and clinical decision support, helping researchers and clinicians navigate the growing volume of medical literature while enabling faster, more reliable insights. Segment 2 – The Evolution of Pharmacy Management Systems with Outcomes Next, we’re joined by Lou Ann Myers from Outcomes to discuss how pharmacy management systems are evolving beyond traditional dispensing. Modern pharmacies require integrated technology connecting billing, treatment planning, clinical tracking, inventory management, and revenue-generating services. Lou Ann shares why these systems must support both clinical services and business sustainability as pharmacies expand into value-based care and new service models. Segment 3 – Emerging Therapies with Cardinal Health In our final segment, we welcome Dr. Fran Gregory, PharmD, Vice President of Emerging Therapies (Cell & Gene, Biosimilars) at Cardinal Health, to discuss one of the most transformative areas in healthcare. Dr. Gregory explores the growing impact of cell and gene therapies and biosimilars, and what these innovations mean for pharmacists, health systems, and specialty pharmacy providers as the industry prepares for new challenges in distribution, access, and reimbursement. About TWIRx (This Week in Pharmacy)TWIRx is the flagship news and commentary podcast from the Pharmacy Podcast Network, delivering weekly insights on the business, technology, and policy shaping the pharmacy profession.
• The Power of Patient 1st Care in Pharmacy and PBM Reform Progress | TWIRx 06.03.2026 1t 23min

  Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week’s show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A.Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers• Why independent pharmacies remain essential healthcare access points• The evolving state of independent pharmacy nationwide• Continued momentum around PBM Reform• Strategic accounting and tax advantages pharmacy operators should understand in today’s challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered• How pharmacy can lead the way in improving patient outcomes• Lessons learned from patient engagement initiatives in the UK healthcare system• Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania• How AHN is expanding pharmacy services across the Greater Pittsburgh region• The role of health system pharmacy in improving access to care• Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week’s episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania. In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law: • Grants new regulatory authority to the Pennsylvania Insurance Department• Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers• Improves transparency requirements for PBM operations• Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. F
• Pharmacy Profit Summit 2026 + Rare Disease Day 2026 | TWIRx 27.02.2026 32min

  On this episode of This Week in Pharmacy, we spotlight two major conversations shaping the future of pharmacy practice in 2026. First, we welcome Dr. Lisa Faast, PharmD, founder of DiversifyRx, to discuss the Pharmacy Profit Summit 2026 and how independent pharmacies can strengthen margins, diversify revenue streams, and build sustainable growth models in today’s reimbursement environment. Then, we turn to Rare Disease Day 2026 with Richard Faris PharmD, Chief Commercial & Clinical Officer at and PANTHERx Rare, to discuss specialty pharmacy leadership, pharmacist impact, and new patient feedback data revealing communication gaps in rare disease care. Segment 1: Pharmacy Profit Summit 2026Guest: Dr. Lisa Faast, PharmD | Founder, DiversifyRx Dr. Faast joins us to break down the vision behind Pharmacy Profit Summit 2026 — an event designed to equip pharmacy owners with practical strategies to increase profitability while maintaining clinical excellence. Key Topics Covered: • Why independent pharmacies must move beyond traditional dispensing revenue • Diversification strategies including niche services and high-value offerings • Real-world financial benchmarks pharmacy owners should track • How mindset, leadership, and data discipline drive sustainable profitability • The importance of collaboration and shared intelligence among pharmacy entrepreneurs The Pharmacy Profit Summit is not just about revenue — it’s about equipping pharmacy owners to compete intelligently in a rapidly consolidating healthcare market. Segment 2: Rare Disease Day 2026Guest: Richard Faris, PharmD | PANTHERx Rare In recognition of Rare Disease Day 2026, we are honored to welcome Richard Ferris, PharmD, to discuss the critical role pharmacists play in specialty pharmacy and rare disease care. PantherRx recently released survey findings examining patient and caregiver experiences within rare disease treatment journeys. Key Study Highlights: • 90% of patients and caregivers report delays due to communication gaps • 68% report waiting for updates from providers, pharmacies, or insurers • 90% say they manage the care process themselves • 72% desire a dedicated care coordinator • 73% agree it is unclear who is responsible for coordinating rare disease care Despite advances in specialty therapeutics, patients are still asking for the fundamentals: clear communication, coordinated care, and personalized support. Richard discusses: • The growing importance of specialty pharmacists as care coordinators • Why rare disease patients often feel burdened by system fragmentation • How specialty pharmacy can close communication gaps • The need for pharmacist-led continuity in complex therapy management Rare Disease Day reminds us that specialty pharmacy is not only about high-cost medications — it is about human connection, long-term coordination, and advocacy for patients navigating some of the most complex clinical journeys in healthcare.  From business sustainability to patient-centered specialty care, this episode reinforces two realities: Pharmacy must remain financially strong to survive.Pharmacists must remain clinically present to lead. As the profession evolves, profitability and patient advocacy are not opposing forces — they are interdependent pillars of pharmacy’s future. Listen now and join the conversation shaping Pharmacy in 2026.
• LTC Rx at Home: Logistics & Advocacy | TWIRx 20.02.2026 1t 8min

  LTC Rx at Home: Logistics & Advocacy | TWIRxRx4Route is a specialized pharmacy delivery management platform and software designed to optimize prescription delivery for pharmacies. It integrates with existing systems to provide real-time tracking, AI-powered route optimization, HIPAA-compliant proof of delivery, and driver management tools. It aims to reduce delivery costs and improve efficiency.Doni Sattarov with Rx4RouteRx4Route.com   Kristen Hutchison - Health Policy and Patient AdvocacyAs a seasoned medical technical writer and chronic illness patient advocate, I meticulously translate intricate medical information into succinct content tailored for diverse audiences, including engineers, clinicians, educators, and advocacy groups.https://www.khutchison.com/
• Valentine’s Day Special 2026 | TWIRx 13.02.2026 1t 19min

  TWIRx – This Week in Pharmacy Episode Date: February 13, 2026Valentine’s Day Special 💘 This week on TWIRx, hosts Stephen Beckman, PharmD and Todd Eury break down the biggest headlines shaping pharmacy, from workforce trends to policy updates and innovation. 💕 Valentine’s Feature: TogetheRx – A Pharmacy Love Story In celebration of Valentine’s Day, we welcome Drs. Mark and Gretchen Garofoli, PharmD, a pharmacy power couple who met at the University of Pittsburgh School of Pharmacy and have built a life and career TogetheRx. Their journey includes raising a family, leading in pharmacy advocacy, podcasting, academic work with WVU School of Pharmacy, and operating a community pharmacy near Morgantown, WV. 🧪 Love Potion Segment: A Historical Rx Dr. Mark Fulton, PharmD, host of the RxTales Podcast, joins the show to explore the surprising history of “love potions” and how folklore intersects with early pharmacy and medicine. 🚀 Innovation Spotlight: RxTransfer & Interoperability We close with Pharmacy 50 Award Winner Alumni 2025, Dr. Lawrence King, PharmD, VP of Product Innovation at Surescripts, discussing RxTransfer, prescription interoperability, and how technology is modernizing pharmacy workflow and patient safety. ❤️ From love stories to pharmacy innovation, this Valentine’s edition celebrates the profession from the heart. Subscribe, listen, and share as we head into Valentine’s Day 2026.  
• The GCR Wake-Up Call: How Small Buying Decisions Are Crushing (or Saving) Pharmacy Margin | TWIRx 06.02.2026 1t 42min

   Independent pharmacies are dispensing more prescriptions than ever—but too many are seeing their profits shrink month after month. In this episode of This Week in Pharmacy, hosts Todd Eury and CEO of MatchRx Johny Kello sit down with Saeed Dinno Director of Pharmacy for a group of independent pharmacies in MI. For a practical, plain-English breakdown of one of the most overlooked metrics impacting pharmacy profitability: GCR, let's dive into this! This episode isn’t about policy debates, compliance theory, or vendor hype. It’s a real-world conversation designed to help pharmacy owners, managers, and buyers understand how everyday sourcing and dispensing behaviors directly influence margin—often without anyone realizing it. Saeed explains what GCR actually measures, what it does not measure, and why two pharmacies filling the exact same prescription can end up with completely different financial outcomes. From convenience buying and emergency orders that become routine, to default NDC selection and a disconnect between the buyer and the bench, the episode highlights the subtle habits that quietly erode profitability over time. More importantly, the conversation delivers actionable steps pharmacies can implement immediately. Saeed outlines the core disciplines that improve performance—smarter buying strategy, better alignment between purchasing and dispensing, and simple operational guardrails that don’t slow workflow. The focus is not on “working harder,” but on working differently. The episode closes with a clear, clip-worthy takeaway: one specific action pharmacy leaders can take this month to start moving the needle. If you’ve ever wondered why your pharmacy is busy but the numbers don’t reflect it, this is an episode you’ll want to listen to twice—and put into practice the very next day.Second segment of TWIRx is with Jonathan Adly, CEO of TJM Labs, to discuss his powerful new book, The Innovative Pharmacy: How to Build an 8-Figure Pharmacy One Idea at a Time. At a time when independent pharmacies are being squeezed by rising labor costs, shrinking reimbursements, and increasing operational complexity, Adly delivers a refreshing message: success is still possible—but it requires innovation, clarity, and execution. Jonathan shares why this book is not a “one-size-fits-all” business blueprint, but a collection of real-world frameworks inspired by hundreds of high-performing pharmacies across the U.S. and Canada. We explore the principles behind sustainable growth, including identifying your ideal customer, building scalable systems through automation, simplifying operations, and playing offense when the math works. This conversation is a call to action for pharmacy leaders ready to build smarter, faster, and stronger—one bold idea at a time.This episode of TWIRx is sponsored by MatchRx, TJM Labs, Independent Pharmacy Cooperative (IPC) and Sykes & Company. 
• Pharmacy Road-map for 2026 and New Opportunities for Growth | TWIRx 30.01.2026 1t 35min

  TWIRx – January 30 | Special Guest: Marc Essensa, CEO of IPC On this episode of This Week in Pharmacy, we welcome Marc Essensa, President and CEO of the Independent Pharmacy Cooperative (IPC), to discuss timely strategies and resources helping independent pharmacies strengthen their businesses in today’s challenging environment. Building Your Independent Pharmacy Business Marc shares insights on navigating reimbursement pressure, improving margins, and leveraging IPC’s purchasing power, data, and strategic tools to support long-term sustainability. The Payment Card Settlement: A Practical Guide We break down IPC’s guidance on the Payment Card Interchange Fee Settlement, which may allow pharmacies that accepted Visa or Mastercard between 2004–2019 to recover funds. Marc explains eligibility, next steps, and how recovered dollars can support cash flow, staffing, technology, or inventory investments. IPC Member Support Services The conversation highlights IPC’s expanded member support offerings, including business consulting, strategic partnerships, wholesale access, and operational resources designed to help independents stay competitive. Legislative & Advocacy Updates Marc also provides updates on IPC’s advocacy efforts at both the state and federal levels, focused on protecting independent pharmacy interests and addressing ongoing policy and reimbursement challenges. 🔗 Resource Mentioned The Payment Card Settlement: A Practical Guide – IPChttps://www.ipcrx.com/pharmacy-blog/news/the-payment-card-settlement-a-practical-guide/ Special guest:  Sakhi Gaurang Patel is a trailblazing PharmD candidate at the UC Irvine School of Pharmacy & Pharmaceutical Sciences and a co-founder of the startup CuraVoice. Recognized for her work in healthcare equity, mentorship, and educational technology, she focuses on improving patient communication and reducing health disparities. Featured Guest: Dr. Jenny Newlon, PharmD — Researcher and Pharmacist with Birth Control Pharmacist In this episode of This Week in Pharmacy, we sit down with Dr. Jenny Newlon to explore how pharmacist consultants, health clinics, and independent pharmacies can build high-value contraception services that meet urgent community needs.We discuss practical strategies for delivering accessible birth control care—especially in areas that have lost Planned Parenthood centers—while creating new revenue models outside the constraints of traditional PBM reimbursement. Dr. Newlon breaks down: How pharmacies can implement contraception services—even with limited staff or clinical infrastructure Ways to deliver value to patients and communities through education, access, and continuity of care Forward-thinking business models that diversify revenue beyond dispensing Tune in to learn how independent pharmacy teams can lead with care, expand women’s health access, and strengthen their role as trusted healthcare providers.Today's "This Week in Pharmacy" is sponsored by Independent Pharmacy Cooperative (IPC)